Sign In
Buy SOLV
$74.56
-2.00 (-2.61%)
At Close: Jun 17, 2026
Why Solventum (SOLV) is a Top Momentum Stock for the Long-Term
10:50am, Thursday, 07'th May 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Solventum Stock Down Despite Q1 Earnings & Revenues Beat Estimates
01:10pm, Wednesday, 06'th May 2026
SOLV beats Q1 earnings and revenue estimates as growth in MedSurg, Dental and HIS offset sales decline and margin pressure.
Solventum (SOLV) Recently Broke Out Above the 20-Day Moving Average
10:35am, Wednesday, 06'th May 2026
Solventum (SOLV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SOLV broke through the 20-day moving average, which suggests a shor
Solventum (SOLV) Recently Broke Out Above the 50-Day Moving Average
10:30am, Wednesday, 06'th May 2026
From a technical perspective, Solventum (SOLV) is looking like an interesting pick, as it just reached a key level of support. SOLV recently overtook the 50-day moving average, and this suggests a sho
Solventum Corporation (SOLV) Q1 2026 Earnings Call Transcript
08:21pm, Tuesday, 05'th May 2026
Solventum Corporation (SOLV) Q1 2026 Earnings Call Transcript
Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates
07:10pm, Tuesday, 05'th May 2026
Solventum (SOLV) came out with quarterly earnings of $1.48 per share, beating the Zacks Consensus Estimate of $1.35 per share. This compares to earnings of $1.34 per share a year ago.
Solventum (SOLV) Reports Q1 Earnings: What Key Metrics Have to Say
07:00pm, Tuesday, 05'th May 2026
While the top- and bottom-line numbers for Solventum (SOLV) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare
Solventum forecasts annual profit at higher end on wound care demand
06:14pm, Tuesday, 05'th May 2026
Medical device maker Solventum said on Tuesday it expects annual profit to be at the higher end of its previous forecast range, primarily driven by strong demand for its wound care and steriliza
Solventum Reports First Quarter 2026 Financial Results
04:05pm, Tuesday, 05'th May 2026
Reported sales decreased (3.0)%; organic sales increased 2.1% Affirms full-year 2026 organic sales growth and free cash flow guidance; estimates adjusted EPS will be toward the high end of existing ra
Solventum to Post Q1 Earnings: Is a Beat Likely for the Stock?
02:46pm, Monday, 04'th May 2026
SOLV gears up for Q1 earnings with modest growth expected, margin pressure looming and cost initiatives plus MedSurg momentum shaping results outlook.
SOLV Energy to Report First Quarter 2026 Financial Results on May 12, 2026
07:05am, Monday, 04'th May 2026
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH) plans to report first quarter 2026 results on Tuesday, May 12, 2026. Management will prese
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (Nasdaq: MWH) (“SOLV”), a leading provider of infrastructure services to the power industry, today announced it has entered into an ag
Peltz's Trian urges Solventum to rightsize costs, divest non-core businesses
06:15am, Friday, 01'st May 2026
Nelson Peltz's Trian Fund Management on Thursday called on Solventum to rightsize overhead costs, divest non-core businesses and improve capital allocation in its latest appeal for a performance
Solventum Stock Is Recovering: What's Going On?
03:12pm, Thursday, 30'th Apr 2026
Solventum Corp (NYSE:SOLV) shares are rebounding on Thursday after activist investor Trian Fund Management released a sharply worded open letter criticizing the company's post‑spin performance and u
Trian Calls on Solventum's Board to Create Value; Publishes Open Letter and Slide Deck
01:05pm, Thursday, 30'th Apr 2026
Solventum's Spin-Out from 3M has Maximized Executive Compensation, Not Shareholder Value Outlines Three Initiatives to Improve Performance and Drive Value Creation at Solventum NEW YORK, April 30, 202
